Ectopic expression of the wild-type or ALS/FTD-associated mutant versions of FUS and TDP-43 is shown to decrease ERMCSs through GSK3β-mediated disruption of VAPB–PTPIP51 interaction (Stoica et al, 2014, 2016). This evidence concerns the gene GSK3B and amyotrophic lateral sclerosis.